A61P 11 - Drugs for disorders of the respiratory system

Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
08/2002
08/28/2002	EP1233776A1 Urotensin-ii cyclic analogs
08/28/2002	EP1233774A1 Urotensin-ii analogs
08/28/2002	EP1233765A1 TREATMENT OF EOSINOPHIL ASSOCIATED PATHOLOGIES BY MODULATING PKC-$g(d) ACTIVITY
08/28/2002	EP1233757A2 Aerosol composition comprising formoterol
08/28/2002	EP1043329B1 Crystal of diuridine tetraphosphate or salt thereof and method for preparing the same, and method for producing said compound
08/28/2002	EP0808173B1 Product and method for preventing respiratory virus infection
08/28/2002	CN1366524A Sulfonamide derivative as matrix metalloproteinase inhibitor
08/28/2002	CN1366518A Biphenyl butyric acid derivative as matrix metalloproteinase inhibitor
08/28/2002	CN1366461A Preventive or therapeutic drugs for dermatitises containing chymase inhibitors as active ingredient
08/28/2002	CN1366459A Preventive or therapeutic drugs for various eosinophilia-realated diseases containing chymase inhibitors as active ingredient
08/28/2002	CN1366042A Process for preparing recombinant deoxyribonuclease I
08/28/2002	CN1365804A Nano medicine 'Shensu' and its preparing process
08/28/2002	CN1365802A Nano antitussive loquat medicine and its preparing process
08/28/2002	CN1365796A Nano medicine 'Xiaoer Qingyan' and its preparing process
08/28/2002	CN1365788A Nano medicine 'Baochi' and its preparing process
08/28/2002	CN1365787A Nano medicine 'Baokening' and its preparing process
08/28/2002	CN1365780A Nano medicine 'Qingguo' and its preparing process
08/28/2002	CN1365775A Nano medicine 'Niuhuang Zhenjing' and its preparing process
08/28/2002	CN1365774A Nano medicine 'Niuhuang Shangqing' and its preparing process
08/28/2002	CN1365760A Nano medicine 'Zhuli Datan' and its preparing process
08/28/2002	CN1365758A Nano antitussive phlegm-resolving medicine and its preparing process
08/28/2002	CN1365757A Nano antitussive asthma-relieving medicine and its preparing process
08/28/2002	CN1365756A Nano antitussive medicine 'Juhong' and its preparing process
08/28/2002	CN1365752A Nano sheep gallbladder medicine and its preparing process
08/28/2002	CN1365748A Nano antitussive almond medicine and its preparing process
08/28/2002	CN1365745A Nano 4-component elecampane inula medicine and its preparing process
08/28/2002	CN1365742A Nano medicine for treating tonsillitis and its preparing process
08/28/2002	CN1365731A Nano medicine for resolving phlegm and treating asthma and its preparing process
08/28/2002	CN1365730A Nano medicine for treating throat disease and its preparing process
08/28/2002	CN1365729A Nano medicine for treating laryngalgia and its preparing process
08/28/2002	CN1365728A Nano medicine for treating throat disease and its preparing process
08/28/2002	CN1365726A Nano medicine for treating cold asthma and its preparing process
08/28/2002	CN1365724A Nano compound antitussive platycodon root medicine and its preparing process
08/28/2002	CN1365722A Nano medicine 'Compound tendrilled fritillary bulb' and its preparing process
08/28/2002	CN1365719A Nano medicine 'Erdong' and its preparing process
08/28/2002	CN1365716A Nano medicine 'Jiuwei Shihuihua' and its preparing process
08/28/2002	CN1365713A Nano medicine for treating ulcer and its preparing process
08/28/2002	CN1365710A Nano inflammation-relieving and antitussive medicine and its preparing process
08/28/2002	CN1365706A Nano medicine for treating infantile cold and its preparing process
08/28/2002	CN1365703A Nano medicine for child to induce diaphoresis and its preparing process
08/28/2002	CN1365696A Nano medicine 'Xiaoer Baishou' and its preparing process
08/28/2002	CN1365695A Nano medicine 'Xiaoer Jindan' and its preparing process
08/28/2002	CN1365690A Nano ganoderma medicine and its preparing process
08/28/2002	CN1365688A Nano medicine 'Ertong Qingfei' and its preparing process
08/28/2002	CN1365680A Nano medicine 'Suzi Jingqi' and its preparing process
08/28/2002	CN1365666A Composition for treating bronchial asthma and allergic rhinitis
08/28/2002	CN1089764C Substituted heterocyclic compounds, preparation method thereof and pharmaceutical compositions containing same
08/28/2002	CN1089759C Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide
08/28/2002	CN1089603C Liquid medicine for treating diseases of eye, ear, nose and throat
08/28/2002	CN1089596C Cough and asthma curing plaster stuck to acupoint
08/27/2002	US6441179 Intermediates useful for the preparation of antihistaminic piperidine derivatives
08/27/2002	US6441040 200 parts s-(3-hydroxypropyl)-l-cysteine, 78 parts corn starch, 1 part talc, and 1 part magnesium stearate does not discolor after 12 months at room temperature, or 3 months at 40 degree c, or 1 month at 50 degree c
08/27/2002	US6441032 Treating systemic lupis and multiple sclerosis
08/27/2002	US6441012 Chemical compounds
08/27/2002	US6441008 Benzamide derivatives as thrombin inhibitors
08/27/2002	US6441004 Monocyte chemoattractant protein-1 inhibitor compounds
08/27/2002	US6440991 Ethers of 7-desmethlrapamycin
08/27/2002	US6440990 O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants
08/27/2002	US6440979 Aryl isoguanines
08/27/2002	US6440973 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
08/27/2002	US6440968 Use of maduraohtalazine derivatives as inhibitors of proinflammatory cytokines
08/27/2002	US6440962 Cardiovascular disorders, antiischemic agents
08/27/2002	US6440959 Inhibitors of cyclin-dependent kinases
08/27/2002	US6440955 Anti-inflammatory agents
08/27/2002	US6440953 Use as an anti-cancer agent and for the treatment of skin diseases such as psoriasis as well as skin conditions such as wrinkles, slack skin, dry skin and insufficient sebum secretion.
08/27/2002	US6440938 Prevention and/or treatment of allergic conditions
08/27/2002	US6440937 Competitive inhibitors of trypsin-like serin proteases, especially thrombin and kininogenases such as kallikrein; thrombin inhibitors, anticoagulants, and antiinflammatory agents
08/27/2002	US6440421 Treatment of bone disorders with adrenomedullin or adrenomedullin agonists
08/27/2002	US6440418 Variable light and heavy amino acid sequences encoded by nucleic acid sequences; seq id no:24, 25 and 26; rheumatoid arthritis, multiple sclerosis, diabetes, and systemic lupus erythematosus; graft versus host disease; gene therapy
08/27/2002	US6440413 Selectively destroying subunit a without destroying subunit b of cholera toxin; enzyme with preponderance of exocellular proteinase produced by a culture of streptomyces fradiae; hyperviscosity of intestinal, bronchial and/or genital mucus
08/27/2002	US6440412 Purified forms of DNase
08/27/2002	US6440391 Management of snoring by oral administration of dimethyl sulfone
08/27/2002	CA2062837C 8-substituted purines as selective adenosine receptor agents
08/27/2002	CA2018592C Polypeptides and polypeptide analogues with inhibitory activity against human elastase
08/22/2002	WO2002064795A2 Putative human enzymes
08/22/2002	WO2002064792A2 Molecules for disease detection and treatment
08/22/2002	WO2002064634A2 Human monoclonal antibodies to fc alpha receptor (cd89)
08/22/2002	WO2002064626A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
08/22/2002	WO2002064616A2 Agonists and antagonists of sphingosine-1-phosphate receptors
08/22/2002	WO2002064595A1 Triazolo compounds as mmp inhibitors
08/22/2002	WO2002064594A2 6-substituted pyrido-pyrimidines
08/22/2002	WO2002064592A1 Tricyclic crf receptor antagonists
08/22/2002	WO2002064591A2 Carboline derivatives
08/22/2002	WO2002064590A2 Carboline derivatives
08/22/2002	WO2002064589A1 Laulimalide derivatives
08/22/2002	WO2002064584A1 Phthalayinone-piperidino-derivatives as pde4 inhibitors
08/22/2002	WO2002064574A2 Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods
08/22/2002	WO2002064572A1 Quinazolines as mmp-13 inhibitors
08/22/2002	WO2002064565A1 Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical
08/22/2002	WO2002064552A1 1g(a)-AMINO-N-HYDROXY-ACETAMIDE DERIVATIVES
08/22/2002	WO2002064550A1 Glucocorticoid receptor modulators
08/22/2002	WO2002064546A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
08/22/2002	WO2002064545A1 Acylated indanyl amines and their use as pharmaceuticals
08/22/2002	WO2002064149A1 Method for the prevention of tissue elastic fiber injury
08/22/2002	WO2002064146A1 4-fluoro-n-indan-2-yl benzamide and its use as pharmaceutical
08/22/2002	WO2002064140A1 Thrombin inhibitors
08/22/2002	WO2002064138A1 Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester
08/22/2002	WO2002064134A2 Use of calcium indomethacin for the treatment of cyclo-oxygenase 2-mediated pathologies
08/22/2002	WO2002064131A2 Inflammation-inhibiting compounds
08/22/2002	WO2002064089A2 Methods of preventing ventilator associated pneumonia by oral administration of antimicrobial ib-367 peptides

1 ... 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 ... 878